|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
47,262,000 |
Market
Cap: |
12.78(B) |
Last
Volume: |
562,747 |
Avg
Vol: |
421,328 |
52
Week Range: |
$205.19 - $276.5 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile United Therapeutics is a biotechnology company. Through its subsidiary, Lung Biotechnology PBC, Co. is focused on addressing the acute national shortage of transplantable lungs and other organs with a variety of technologies that either delay the need for such organs or expand the supply. Co. markets and sells the following commercial therapies to treat pulmonary arterial hypertension: Remodulin® (treprostinil) Injection; Tyvaso® (treprostinil) Inhalation Solution; Orenitram® (treprostinil) Extended-Release Tablets; and Adcirca® (tadalafil) Tablets. In the U.S., Co. also markets and sells an oncology product, Unituxin® (dinutuximab) Injection, for the treatment of high-risk neuroblastoma.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
577,395 |
619,080 |
681,963 |
1,833,148 |
Total Sell Value |
$140,716,560 |
$150,163,103 |
$164,291,315 |
$450,661,443 |
Total People Sold |
8 |
8 |
8 |
10 |
Total Sell Transactions |
69 |
79 |
91 |
260 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mahon Paul A |
EVP & GENERAL COUNSEL |
|
2024-03-07 |
4 |
OE |
$117.76 |
$706,560 |
D/D |
6,000 |
42,599 |
|
- |
|
Rothblatt Martine A |
CHAIRPERSON & CEO |
|
2024-03-06 |
4 |
AS |
$230.28 |
$3,543,793 |
D/D |
(15,000) |
130 |
|
15% |
|
Rothblatt Martine A |
CHAIRPERSON & CEO |
|
2024-03-06 |
4 |
OE |
$129.49 |
$1,942,350 |
D/D |
15,000 |
15,130 |
|
- |
|
Thompson Tommy G |
|
|
2024-03-06 |
4 |
D |
$236.97 |
$473,940 |
D/D |
(2,000) |
8,480 |
|
- |
|
Thompson Tommy G |
|
|
2024-03-06 |
4 |
OE |
$88.03 |
$176,060 |
D/D |
2,000 |
10,480 |
|
- |
|
Giltner Richard |
|
|
2024-03-06 |
4 |
D |
$236.97 |
$2,369,700 |
D/D |
(10,000) |
15,620 |
|
- |
|
Giltner Richard |
|
|
2024-03-06 |
4 |
OE |
$88.03 |
$880,300 |
D/D |
10,000 |
25,620 |
|
- |
|
Rothblatt Martine A |
CHAIRPERSON & CEO |
|
2024-03-05 |
4 |
AS |
$230.36 |
$1,454,886 |
D/D |
(6,300) |
130 |
|
19% |
|
Rothblatt Martine A |
CHAIRPERSON & CEO |
|
2024-03-05 |
4 |
OE |
$129.49 |
$815,787 |
D/D |
6,300 |
6,430 |
|
- |
|
Rothblatt Martine A |
CHAIRPERSON & CEO |
|
2024-03-04 |
4 |
AS |
$230.58 |
$212,071 |
D/D |
(915) |
130 |
|
19% |
|
Rothblatt Martine A |
CHAIRPERSON & CEO |
|
2024-03-04 |
4 |
OE |
$129.49 |
$118,483 |
D/D |
915 |
1,045 |
|
- |
|
Rothblatt Martine A |
CHAIRPERSON & CEO |
|
2024-03-01 |
4 |
AS |
$231.11 |
$3,493,352 |
D/D |
(15,000) |
130 |
|
18% |
|
Rothblatt Martine A |
CHAIRPERSON & CEO |
|
2024-03-01 |
4 |
OE |
$129.49 |
$1,942,350 |
D/D |
15,000 |
15,130 |
|
- |
|
Thompson Tommy G |
|
|
2024-03-01 |
4 |
D |
$231.92 |
$463,840 |
D/D |
(2,000) |
8,480 |
|
- |
|
Thompson Tommy G |
|
|
2024-03-01 |
4 |
OE |
$88.03 |
$176,060 |
D/D |
2,000 |
10,480 |
|
- |
|
Kurzweil Ray |
|
|
2024-02-23 |
4 |
D |
$227.03 |
$3,405,450 |
D/D |
(15,000) |
11,180 |
|
- |
|
Kurzweil Ray |
|
|
2024-02-23 |
4 |
OE |
$88.03 |
$1,320,450 |
D/D |
15,000 |
26,180 |
|
- |
|
Thompson Tommy G |
|
|
2024-02-23 |
4 |
D |
$227.03 |
$454,060 |
D/D |
(2,000) |
8,480 |
|
- |
|
Thompson Tommy G |
|
|
2024-02-23 |
4 |
OE |
$88.03 |
$176,060 |
D/D |
2,000 |
10,480 |
|
- |
|
Patusky Christopher |
|
|
2024-02-23 |
4 |
S |
$224.00 |
$376,320 |
D/D |
(1,680) |
4 |
|
-18% |
|
Mahon Paul A |
EVP & GENERAL COUNSEL |
|
2024-02-15 |
4 |
AS |
$214.54 |
$1,291,885 |
D/D |
(6,000) |
36,599 |
|
27% |
|
Mahon Paul A |
EVP & GENERAL COUNSEL |
|
2024-02-15 |
4 |
OE |
$117.76 |
$706,560 |
D/D |
6,000 |
42,599 |
|
- |
|
Mahon Paul A |
EVP & GENERAL COUNSEL |
|
2024-02-01 |
4 |
AS |
$213.58 |
$1,290,083 |
D/D |
(6,000) |
36,599 |
|
26% |
|
Mahon Paul A |
EVP & GENERAL COUNSEL |
|
2024-02-01 |
4 |
OE |
$117.76 |
$706,560 |
D/D |
6,000 |
42,599 |
|
- |
|
Mahon Paul A |
EVP & GENERAL COUNSEL |
|
2024-01-18 |
4 |
AS |
$217.55 |
$1,312,322 |
D/D |
(6,000) |
36,599 |
|
25% |
|
5060 Records found
|
|
Page 7 of 203 |
|
|